Improving treatment and understanding

Our academic research


Jonathan & Rachna are key opinion leaders in aesthetics and thyroid eye disease, and are on the editorial board of the Plastic Maxillofacial & Aesthetic Surgery Journal.

Chevron Down Blue
Research Hero

List of Publications

Research we are part of


Sensitive cilia – eyelashes in health and disease.

Murthy R & Roos JCP.

The PMFA Journal October/November 2020;8(1):11-14


Improving aseptic injection standards in aesthetic clinical practice.

Murthy R, Eccleston D, Mckeown D, Parikh A, Shotter S.

Dermatol Ther. 2020 Oct 17;e14416


Factors influencing pre-injection aspiration for hyaluronic acid fillers: A systematic literature review and meta-analysis.

Kapoor KM, Murthy R, Hart SLA et al.

Dermatol Ther. 2020 Oct 1;e14360


Teprotumumab for the treatment of Active Thyroid Eye disease.

Roos JC, Hyry HI, Murthy R.

New England Journal of Medicine 2020 05;382(20):1959.


Inhibition of fibrotic contraction by Sirolimus (Rapamycin) in an ex vivo model of Thyroid Eye Disease

Roos JCP, Eglitis V, Murthy R.

Ophthalmic Plastic and Reconstructive Surgery. Ophthalmic Plast Reconstr Surg. 2020; (accepted, in production)


Periocular hyaluronic acid fillers: applications, implications, complications.

Murthy R, Roos JC, Goldberg RA.

Curr Opin Ophthalmol. 2019 Sep;30(5):395-400


Update on the clinical assessment and management of thyroid eye disease.

Roos JC, Murthy R.

Curr Opin Ophthalmol. 2019 Sep;30(5);401-406


Sirolimus (Rapamycin) for the targeted treatment of the fibrotic sequelae of Graves’ orbitopathy.

Roos JC, Murthy R.

Eye (Lond). 2019 Apr;33(4):679-682